The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPrimorus Inv. Regulatory News (PRIM)

Share Price Information for Primorus Inv. (PRIM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3.75
Bid: 3.50
Ask: 4.00
Change: 0.00 (0.00%)
Spread: 0.50 (14.286%)
Open: 3.75
High: 3.75
Low: 3.75
Prev. Close: 3.75
PRIM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Further re Investment in Mustang

19 Jan 2022 08:01

RNS Number : 9393Y
Primorus Investments PLC
19 January 2022
 

Primorus Investments plc

 

("Primorus" or the "Company")

 

Revised Backstop arrangements for the Investment in Mustang Energy PLC

 

Primorus Investments plc (AIM: PRIM) provides an update in relation to its investment in Mustang Energy PLC ("MUST").

 

As announced by MUST on 17 January 2022, the notice period for the Backstop Arrangement was extended to 18 January 2022 to enable the parties more visibility as to the potential outcome of the VRFB-H litigation and more time to negotiate alternative arrangements. Under the terms of the current Backstop Arrangement, Primorus would redeem its Convertible Loan Notes (CLN) and receive the full value of its investment (and interest) through the allocation of Bushveld Minerals PLC ("BMN") shares.

 

BMN, MUST, the other investors in the CLN and Primorus have been negotiating alternatives to the Backstop Arrangement. This is to ensure Primorus can maintain an interest in this transaction, but on a risk adjusted basis.

 

The renegotiated Backstop agreement has been agreed as follows:

· Primorus has transferred $1,000,000 of its $2,500,000 CLN instruments to certain existing CLN investors (the "Investors"), in return for Primorus receiving $1,000,000 in cash. It has also transferred the associated warrants (representing 40% of the overall warrants based on 1 warrant for every two shares converted under the CLN) to subscribe for new ordinary shares in MUST to the Investors.

· The interest accrued to date, $72,054.79 will also been settled, in cash, by the Investors.

· The Backstop Date for the remaining CLN has been extended to 28 February 2022.

· The terms of the Backstop have also been amended and, at Primorus' sole discretion, on 28 February 2022 it has the option to:

o Convert its outstanding CLN into Mustang shares in accordance with the original agreement; or

o Transfer the outstanding CLN plus interest accrued to BMN and, at BMN's sole discretion, BMN shall either repay the CLN (and accrued interest) to Primorus or enter into a Convertible Loan Note with Primorus on the terms set out below. If Primorus selects to transfer the outstanding CLN to BMN, it will also transfer to BMN the balance of its warrants to subscribe for new ordinary shares in MUST.

 

BMN Convertible Loan Note (BCLN)

 

If BMN enacts the BCLN it shall be based on the key terms set out below:

 

· An overall duration of 18 months with a maturity date of 14 July 2023;

· It shall bear interest at the annual rate of 10%;

· It shall allow Primorus to convert 1/6 of the total BCLN every three months into new ordinary shares in BMN and any unconverted BCLN shall roll over and be added onto the following three months allocation;

· Primorus is only permitted to issue a single conversion notice in each of the three-month periods (effectively six conversion notices over the 18 month term) and BMN has the right to purchase, for cash, some or all of the shares that are proposed for conversion in accordance with the Payment Mechanism (stated below);

· Upon conversion of any BCLN by Primorus and where the value of the conversion shares exceeds £250,000 in a single transaction or series of transactions within a three month period, Primorus must give written notice BMN allowing them five business days, following receipt of such notice, to arrange the sale of such shares to a purchaser of its choice at a price agreed with Primorus, failing which Primorus shall be free to dispose of any or all of such Shares as it sees fit.

· The total number of shares to be allocated in BMN at the date of transfer (28 February 2022) will be calculated on the basis of the prior 20 day VWAP as stated on Bloomberg

· BMN shall have the right to redeem all or part of the CLN at any time during its term by paying, in cash, the par value of the BCLN (plus accrued interest) to Primorus. In addition, if the BMN share price is higher than the par value of the BCLN then BMN shall also pay the difference, in cash, between the two prices based on the prior 10 day VWAP commencing from the redemption date (referred to above as the "Payment Mechanism").

 

Primorus has agreed to the extension because it believes this will allow sufficient time for the litigation relating to the Enerox transaction to be finalised. If the litigation is settled in favour of MUST then Primorus has retained the option to complete 60% of the originally intended investment. If the litigation does not get settled in favour of MUST then Primorus has substantially protected itself from any downside. 

 

Primorus would like to thank BMN and the Investors for their support and willingness to amend the Backstop Arrangement, which ensures Primorus can maintain an interest in this transaction.

 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors are responsible for the release of this announcement.

Forward Looking Statements

This announcement contains forward-looking statements relating to expected or anticipated future events and anticipated results that are forward-looking in nature and, as a result, are subject to certain risks and uncertainties, such as general economic, market and business conditions, competition for qualified staff, the regulatory process and actions, technical issues, new legislation, uncertainties resulting from potential delays or changes in plans, uncertainties resulting from working in a new political jurisdiction, uncertainties regarding the results of exploration, uncertainties regarding the timing and granting of prospecting rights, uncertainties regarding the Company's ability to execute and implement future plans, and the occurrence of unexpected events. Actual results achieved may vary from the information provided herein as a result of numerous known and unknown risks and uncertainties and other factors.

 

 

 

For further information please contact:

 

Primorus Investments plc

Matthew Beardmore, Chief Executive Officer

 

+44 (0)20 8154 7907

 

Nominated Adviser

Cairn Financial Advisers LLP

Sandy Jamieson/James Caithie

 

+44 (0) 20 7213 0880

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURBKCBPOBKKCDD
Date   Source Headline
26th Sep 20177:00 amRNSQuarterly Investor Update
18th Sep 20177:00 amRNSInvestment in Stream TV
12th Sep 20177:01 amRNSHolding(s) in Company
12th Sep 20177:00 amRNSHolding(s) in Company
8th Sep 20177:00 amRNSHorse Hill Update
6th Sep 20177:00 amRNSHalf-year Report
1st Sep 20179:34 amRNSNew Investments
23rd Aug 201711:47 amRNSNew Investments
4th Aug 20179:39 amRNSDirector/PDMR Shareholding
3rd Aug 20177:00 amRNSDirector/PDMR Shareholding
2nd Aug 20177:00 amRNSIssue of Equity
19th Jul 20171:52 pmRNSStmnt re Share Price Movement
10th Jul 20177:00 amRNSHorse Hill Planning Application Update
7th Jul 201710:20 amRNSIssue of Equity
6th Jun 20179:40 amRNSDirector/PDMR Shareholding
31st May 201710:24 amRNSDirector/PDMR Shareholding
26th May 20179:45 amRNSDirector/PDMR Shareholding
24th May 201712:20 pmRNSDirector/PDMR Shareholding
22nd May 20171:22 pmRNSPosting of Report and Accounts
22nd May 20171:02 pmRNSFundraising Update
10th May 201712:00 pmRNSFinal Results
2nd May 20177:00 amRNSInvestment Update for Fresho
4th Apr 20177:00 amRNSHorse Hill Update
20th Mar 201712:11 pmRNSResult of GM
3rd Mar 20177:00 amRNSPlacing and Notice of General Meeting
7th Feb 20177:00 amRNSHorse Hill Update
7th Dec 20167:00 amRNSChange of Name
30th Nov 20161:46 pmRNSChange of Name
24th Nov 20165:37 pmRNSResult of AGM
17th Oct 20167:00 amRNSHorse Hill Update
27th Sep 20167:00 amRNSHalf-year Report
22nd Sep 20167:00 amRNSInvestment in Fresho Pty Ltd
19th Jul 20167:00 amRNSHorse Hill Update
5th Jul 20167:00 amRNSKey Licence Conversion, Weald Basin
1st Jul 20167:00 amRNSCompetent Person's Report on Dolgellau Gold Belt
24th May 201612:30 pmRNSFinal Results
21st Mar 20168:00 amRNSHorse Hill Update
9th Mar 20167:00 amRNSFurther Update on Horse Hill-1 Flow Test
2nd Mar 20168:00 amRNSIssue of Equity
2nd Mar 20167:00 amRNSFurther Update on Horse Hill-1 Flow Test
1st Mar 20168:00 amRNSIssue of Equity
1st Mar 20167:00 amRNSFurther Update on Horse Hill-1 Flow Test
25th Feb 20163:49 pmRNSIssue of Equity
24th Feb 20163:38 pmRNSIssue of Equity
17th Feb 20167:00 amRNSHorse Hill-1, Further Update on Flow Test
16th Feb 20167:00 amRNSHorse Hill-1 Oil Discovery, Update on Flow Test
8th Feb 20167:00 amRNSHorse Hill Flow Test Operations Commence
4th Jan 20167:00 amRNSHorse Hill-1 Final Flow Test Consent
30th Nov 20153:33 pmRNSBoard Changes and Grant of Options
30th Nov 201511:15 amRNSHorse Hill-1 Flow Test Consent

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.